See more : Qingdao Port International Co., Ltd. (6198.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Procyon Corporation (PCYN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Procyon Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Gaekwar Mills Ltd (ZGAEKWAR.BO) Income Statement Analysis – Financial Results
- Archimedes Tech SPAC Partners Co. (ATSPU) Income Statement Analysis – Financial Results
- Garanti Faktoring A.S. (GARFA.IS) Income Statement Analysis – Financial Results
- Reliance Capital Limited (RELCAPITAL.NS) Income Statement Analysis – Financial Results
- China MeiDong Auto Holdings Limited (1268.HK) Income Statement Analysis – Financial Results
Procyon Corporation (PCYN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://procyoncorp.com
About Procyon Corporation
Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems primarily in the United States. The company offers advanced skin and wound care products, including the hydrogel wound dressing products, post op surgical kits, saline wound washes, care lotions, and barrier lotions to promote healing in wound and problematic skin conditions, as well as hand sanitizer under the AMERIGEL brand name. It also provides Bioactive Collagen products in the form of power and matrix under the HELIX3 brand name. In addition, the company offers wound care products, such as calcium alginate, foam, gauze, and hyrdocolloid dressing products; and wound care kits, which include calcium alginate, collagen matrix, collagen powder, foam, and hydrogel wound care kits under the AMERX brand name, as well as compression garment line products under the EXTREMIT-EASE name. It sells its products through distributors to institutional customers, such as hospitals, wound care clinics, nursing homes, home health agencies, physicians, and health care practitioners; and retail customers through direct sales, and internet sales, as well as through independent and retail chain drug stores. The company was incorporated in 1987 and is based in Clearwater, Florida.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.98M | 4.69M | 4.84M | 4.72M | 4.33M | 4.19M | 4.02M | 4.01M | 3.45M | 2.77M | 2.84M | 2.75M | 2.80M | 2.70M | 2.55M | 2.37M | 2.56M | 2.54M | 2.31M | 2.20M | 2.02M | 1.65M | 1.36M | 1.15M | 702.86K | 300.00K | 371.20K | 215.56K | 308.67K |
Cost of Revenue | 1.09M | 1.12M | 1.36M | 1.33M | 1.13M | 1.14M | 1.08M | 1.26M | 1.03M | 808.51K | 708.88K | 700.87K | 701.87K | 596.89K | 542.79K | 452.02K | 630.46K | 600.18K | 519.89K | 531.50K | 464.76K | 363.82K | 262.64K | 265.06K | 127.92K | 100.00K | 181.25K | 96.95K | 90.60K |
Gross Profit | 3.89M | 3.57M | 3.49M | 3.39M | 3.20M | 3.05M | 2.94M | 2.75M | 2.42M | 1.96M | 2.13M | 2.05M | 2.10M | 2.11M | 2.00M | 1.91M | 1.93M | 1.94M | 1.79M | 1.67M | 1.56M | 1.28M | 1.10M | 881.74K | 574.94K | 200.00K | 189.95K | 118.61K | 218.07K |
Gross Profit Ratio | 78.07% | 76.16% | 71.98% | 71.80% | 73.82% | 72.76% | 73.02% | 68.53% | 70.12% | 70.83% | 75.03% | 74.51% | 74.94% | 77.91% | 78.69% | 80.89% | 75.40% | 76.34% | 77.53% | 75.82% | 77.05% | 77.89% | 80.66% | 76.89% | 81.80% | 66.67% | 51.17% | 55.02% | 70.65% |
Research & Development | 0.00 | 30.60K | 30.00K | 30.90K | 23.09K | 33.14K | 41.75K | 31.30K | 20.04K | 22.83K | 21.18K | 2.17K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 36.63K | 0.00 | 48.12K | 0.00 | 0.00 |
General & Administrative | 4.12M | 3.67M | 3.72M | 3.06M | 3.05M | 2.95M | 2.81M | 2.72M | 2.52M | 2.30M | 2.06M | 2.06M | 1.87M | 1.77M | 1.82M | 1.75M | 1.79M | 1.69M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 536.00K | 473.00K | 240.00K | 400.00K | 576.00K | 608.00K | 478.00K | 451.00K | 416.00K | 409.00K | 448.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 4.12M | 3.67M | 3.72M | 3.06M | 3.05M | 2.95M | 2.81M | 2.72M | 2.52M | 2.30M | 2.06M | 2.06M | 1.87M | 1.77M | 1.82M | 1.75M | 1.79M | 1.69M | 1.44M | 1.42M | 1.34M | 1.21M | 1.20M | 1.57M | 841.22K | 800.00K | 460.05K | 362.80K | 425.21K |
Other Expenses | 0.00 | 20.19K | 0.00 | 0.00 | 10.00K | 0.00 | 0.00 | 31.30K | 300.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.44M | 1.42M | 1.34M | 1.21M | 1.20M | 1.57M | 847.33K | 800.00K | 995.26K | 819.89K | 740.63K |
Operating Expenses | 4.12M | 3.67M | 3.72M | 3.06M | 3.05M | 2.95M | 2.81M | 2.72M | 2.52M | 2.30M | 2.06M | 2.06M | 1.87M | 1.77M | 1.82M | 1.75M | 1.79M | 1.69M | 1.44M | 1.42M | 1.34M | 1.21M | 1.20M | 1.57M | 883.96K | 800.00K | 1.04M | 819.89K | 740.63K |
Cost & Expenses | 5.22M | 4.78M | 5.08M | 4.39M | 4.18M | 4.09M | 3.89M | 3.98M | 3.55M | 3.11M | 2.77M | 2.76M | 2.57M | 2.37M | 2.37M | 2.20M | 2.42M | 2.29M | 1.96M | 1.95M | 1.80M | 1.57M | 1.46M | 1.84M | 1.01M | 900.00K | 1.22M | 916.84K | 831.22K |
Interest Income | 24.64K | 11.82K | 1.80K | 1.23K | 1.75K | 2.24K | 846.00 | 1.87K | 1.40K | 2.08K | 3.57K | 3.42K | 2.39K | 2.73K | 6.66K | 11.02K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 1.80K | 2.17K | 0.00 | 0.00 | 0.00 | 2.85K | 4.47K | 200.00 | 0.00 | 3.62K | 16.63K | 27.63K | 32.08K | 33.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 270.73K | 231.80K | 214.41K | 164.31K | 53.94K | 52.65K | 47.86K | 45.68K | 37.71K | 35.87K | 32.80K | 32.52K | 33.45K | 35.74K | 28.99K | 32.22K | 35.80K | 36.21K | 23.59K | 27.62K | 24.03K | 15.98K | 13.17K | 9.86K | 6.11K | 0.00 | 6.01K | 9.62K | 9.40K |
EBITDA | 99.45K | 166.43K | -21.01K | 900.28K | 214.00K | 149.72K | 174.95K | 77.51K | 232.34K | -303.42K | 101.72K | 23.42K | 267.20K | 373.77K | 217.69K | 203.92K | 176.28K | 280.00K | 381.68K | 277.93K | 245.79K | 89.44K | -88.21K | -682.08K | -302.91K | -607.32K | -847.43K | -691.66K | -513.16K |
EBITDA Ratio | 2.00% | 2.87% | -0.43% | 10.39% | 3.96% | 3.57% | 4.37% | 1.93% | 6.83% | -10.95% | 3.58% | 0.85% | 9.54% | 13.83% | 8.55% | 8.62% | 6.88% | 11.03% | 16.48% | 12.62% | 11.79% | 5.43% | -6.53% | -59.48% | -43.10% | -200.00% | -227.16% | -320.86% | -166.25% |
Operating Income | -231.71K | -97.38K | -237.22K | 324.77K | 153.02K | 97.07K | 127.09K | 29.96K | -103.57K | -341.36K | 65.35K | -12.52K | 231.37K | 335.33K | 182.04K | 160.69K | 140.48K | 243.79K | 358.09K | 250.32K | 221.77K | 73.46K | -101.38K | -691.94K | -309.02K | -600.00K | -853.44K | -701.28K | -522.56K |
Operating Income Ratio | -4.65% | -2.08% | -4.90% | 6.88% | 3.53% | 2.32% | 3.16% | 0.75% | -3.00% | -12.32% | 2.30% | -0.46% | 8.26% | 12.41% | 7.15% | 6.79% | 5.48% | 9.61% | 15.48% | 11.39% | 10.95% | 4.46% | -7.46% | -60.34% | -43.97% | -200.00% | -229.91% | -325.33% | -169.29% |
Total Other Income/Expenses | 60.42K | 32.01K | 1.80K | 507.12K | 7.05K | 2.24K | 556.00 | -978.00 | 293.74K | 1.88K | 3.57K | -193.00 | -14.24K | -24.92K | -25.41K | -22.78K | -21.49K | -22.26K | 139.00 | -12.66K | -26.71K | 80.00 | 446.00 | 0.00 | 0.00 | 607.32K | -4.22K | 0.00 | 0.00 |
Income Before Tax | -171.28K | -65.37K | -235.41K | 831.89K | 160.07K | 99.31K | 127.64K | 28.99K | 190.17K | -339.49K | 68.92K | -12.71K | 217.13K | 310.40K | 156.63K | 137.91K | 118.99K | 221.53K | 358.23K | 237.65K | 195.06K | 73.54K | -100.93K | 0.00 | 0.00 | 0.00 | -857.66K | 0.00 | 0.00 |
Income Before Tax Ratio | -3.44% | -1.39% | -4.86% | 17.63% | 3.69% | 2.37% | 3.17% | 0.72% | 5.51% | -12.25% | 2.43% | -0.46% | 7.75% | 11.49% | 6.15% | 5.83% | 4.64% | 8.73% | 15.49% | 10.81% | 9.63% | 4.47% | -7.43% | 0.00% | 0.00% | 0.00% | -231.05% | 0.00% | 0.00% |
Income Tax Expense | 169.86K | -15.13K | -25.62K | 64.31K | 48.41K | 72.09K | 383.37K | 16.61K | 80.60K | -121.22K | 45.31K | 91.59K | 88.63K | 117.86K | 58.79K | 43.38K | -674.19K | -276.85K | 16.00K | -77.19K | -63.00K | 41.45K | 36.54K | -5.26K | 8.99K | 600.00K | 2.02K | -3.97K | -3.16K |
Net Income | -341.14K | -50.25K | -209.79K | 694.35K | 111.66K | 27.22K | -255.73K | 12.38K | 109.57K | -218.27K | 23.61K | -104.30K | 128.50K | 192.90K | 122.77K | 24.68K | 793.18K | 498.38K | 342.23K | 314.84K | 258.06K | 32.01K | -137.91K | -686.69K | -318.01K | -600.00K | -855.46K | -697.31K | -519.39K |
Net Income Ratio | -6.84% | -1.07% | -4.33% | 14.71% | 2.58% | 0.65% | -6.36% | 0.31% | 3.18% | -7.87% | 0.83% | -3.79% | 4.59% | 7.14% | 4.82% | 1.04% | 30.95% | 19.65% | 14.79% | 14.32% | 12.75% | 1.94% | -10.15% | -59.88% | -45.24% | -200.00% | -230.46% | -323.49% | -168.27% |
EPS | -0.04 | -0.01 | -0.03 | 0.08 | 0.01 | 0.00 | -0.03 | 0.00 | 0.01 | -0.03 | 0.00 | -0.01 | 0.01 | 0.02 | 0.01 | 0.00 | 0.10 | 0.06 | 0.04 | 0.04 | 0.03 | 0.00 | -0.02 | -0.09 | -0.06 | -0.11 | -0.21 | -0.19 | -0.14 |
EPS Diluted | -0.04 | -0.01 | -0.03 | 0.08 | 0.01 | 0.00 | -0.03 | 0.00 | 0.01 | -0.03 | 0.00 | -0.01 | 0.01 | 0.02 | 0.01 | 0.00 | 0.09 | 0.06 | 0.04 | 0.04 | 0.03 | 0.00 | -0.02 | -0.09 | -0.06 | -0.11 | -0.21 | -0.19 | -0.14 |
Weighted Avg Shares Out | 8.12M | 8.09M | 8.09M | 8.09M | 8.09M | 8.09M | 8.08M | 8.06M | 8.06M | 7.92M | 8.06M | 8.06M | 8.06M | 8.06M | 8.06M | 8.06M | 8.05M | 8.05M | 8.04M | 8.05M | 8.04M | 7.91M | 7.82M | 7.82M | 5.59M | 5.38M | 4.17M | 3.64M | 3.64M |
Weighted Avg Shares Out (Dil) | 8.12M | 8.09M | 8.09M | 8.32M | 8.32M | 8.32M | 8.08M | 8.28M | 8.25M | 8.06M | 8.25M | 8.06M | 8.25M | 8.25M | 8.25M | 8.27M | 8.43M | 8.36M | 8.36M | 8.36M | 8.41M | 8.36M | 7.86M | 7.82M | 5.59M | 5.38M | 4.17M | 3.64M | 3.64M |
Source: https://incomestatements.info
Category: Stock Reports